CGEN Competitors & Alternatives

Compare Compugen with similar stocks in the same industry

Biotechnology

CGEN

Main Stock
$2.02
-0.98%
Tradestie Score
45
Market Cap
$149.66M
P/E Ratio
5.4
Revenue Growth
102.1%
Analyst Upside
+137.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 4/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Machine learning target prediction, Immuno-oncology target discovery, Computational antibody design
Major Customers 3
Pharmaceutical collaboration partners Academic research institutions Biotech licensees
Critical Suppliers 3
Contract research organizations (CROs) Antibody manufacturing CMOs Genomic data providers
Direct Ecosystem Rivals 4

Top Competitors

220 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SLN Silence Therapeutics Plc American Depository Share
$19.80
$240.89M - 45 Compare
OABI OmniAb, Inc. Common Stock
$5.05
+3.27%
$231.77M - 56 Compare
SGMT Sagimet Biosciences Inc. Series A Common Stock
$9.85
-2.76%
$227.00M - 50 Compare
SLS SELLAS Life Sciences Group, Inc. Common Stock
$19.15
+156.36%
$211.22M - 32 Compare
ACRS Aclaris Therapeutics, Inc.
$3.38
-6.24%
$202.58M - 40 Compare
CBIO Crescent Biopharma, Inc. Common Stock
$13.04
-3.41%
$199.71M - 42 Compare
FBRX Forte Biosciences, Inc. Common Stock
$76.99
+0.03%
$180.53M - 54 Compare
MCRB Seres Therapeutics, Inc.
$1.41
$179.47M - 44 Compare
ACHV Achieve Life Sciences, Inc.
$6.78
+0.89%
$158.43M - 56 Compare
NVCT Nuvectis Pharma, Inc. Common Stock
$19.20
+0.47%
$154.27M - 54 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2836)

220 stocks in this industry